Healthcare Utilization and Statin Re-Initiation Among Medicare Beneficiaries With a History of Myocardial Infarction

被引:7
作者
Booth, John N., III [1 ]
Colantonio, Lisandro D. [1 ]
Rosenson, Robert S. [4 ]
Safford, Monika M. [5 ]
Chen, Ligong [1 ]
Kilgore, Meredith L. [2 ]
Brown, Todd M. [3 ]
Taylor, Benjamin [6 ]
Dent, Ricardo [6 ]
Monda, Keri L. [6 ]
Muntner, Paul [1 ]
Levitan, Emily B. [1 ]
机构
[1] Univ Alabama Birmingham, Dept Epidemiol, 1700 Univ Blvd,LHL 452, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Hlth Care Org & Policy, Birmingham, AL USA
[3] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
[4] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA
[5] Weill Cornell Med, Dept Med, New York, NY USA
[6] Amgen Inc, Ctr Observat Res, Thousand Oaks, CA 91320 USA
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2018年 / 7卷 / 10期
关键词
case-crossover; discontinuation; re-initiation; statin; statin discontinuation; statin re-initiation; CASE-CROSSOVER DESIGN; SECONDARY PREVENTION; THERAPY; DISCONTINUATION; ADHERENCE; ATORVASTATIN; PERSISTENCE; DISEASE; EVENTS; TRIALS;
D O I
10.1161/JAHA.117.008462
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Contact with the healthcare system represents an opportunity for individuals who discontinue statins to re-initiate treatment. To help identify opportunities for healthcare providers to emphasize the risk-lowering benefits accrued through restarting statins, we determined the types of healthcare utilization associated with statin re-initiation among patients with history of a myocardial infarction. Methods and Results-Medicare beneficiaries with a statin pharmacy fill claim within 30 days of hospital discharge for a myocardial infarction in 2007 to 2012 (n = 158 795) were followed for 182 days post discharge to identify treatment discontinuation, defined as 60 continuous days without statins (n = 24 461). Re-initiation was defined as a statin fill within 365 days of the discontinuation date (n = 13 136). Using a case-crossover study design and each beneficiary as their own control, healthcare utilization during 0 to 14 days before statin re-initiation (case period) was compared with healthcare utilization 30 to 44 days before statin re-initiation (control period). The mean age of beneficiaries was 75.4 years; 52.8% were women and 81.9% were white. For routine healthcare utilization, the odds ratio (95% confidence interval) for statin re-initiation associated with lipid panel testing was 2.65 (1.93-3.65), outpatient primary care was 1.31 (1.23-1.40), and outpatient cardiologist care was 1.38 (1.28-1.50). For acute healthcare utilization, the odds ratio (95% confidence interval) for statin re-initiation associated with emergency department visits was 1.77 (1.31-2.40), coronary heart disease (CHD) hospitalizations was 3.16 (2.41-4.14) and noncoronary heart disease hospitalizations was 1.73 (1.49-2.01). Conclusions-The weaker association of routine versus acute healthcare utilization with statin re-initiation suggests missed opportunities to reinforce the importance of statin therapy for secondary prevention.
引用
收藏
页数:25
相关论文
共 22 条
[1]   Long-term persistence in use of statin therapy in elderly patients [J].
Benner, JS ;
Glynn, RJ ;
Mogun, H ;
Neumann, PJ ;
Weinstein, MC ;
Avorn, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (04) :455-461
[2]   Statin Discontinuation, Reinitiation, and Persistence Patterns Among Medicare Beneficiaries After Myocardial Infarction A Cohort Study [J].
Booth, John N., III ;
Colantonio, Lisandro D. ;
Chen, Ligong ;
Rosenson, Robert S. ;
Monda, Keri L. ;
Safford, Monika M. ;
Kilgore, Meredith L. ;
Brown, Todd M. ;
Taylor, Benjamin ;
Dent, Ricardo ;
Muntner, Paul ;
Levitan, Emily B. .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2017, 10 (10)
[3]   Physician follow-up and provider continuity are associated with long-term medication adherence - A study of the dynamics of statin use [J].
Brookhart, M. Alan ;
Patrick, Amanda R. ;
Schneeweiss, Sebastian ;
Avorn, Jerry ;
Dormuth, Colin ;
Shrank, William ;
van Wijk, Boris L. G. ;
Cadarette, Suzanne M. ;
Canning, Claire F. ;
Solomon, Daniel H. .
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (08) :847-852
[4]   Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].
Cannon, CP ;
Braunwald, E ;
McCabe, CH ;
Rader, DJ ;
Rouleau, JL ;
Belder, R ;
Joyal, SV ;
Hill, KA ;
Pfeffer, MA ;
Skene, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1495-1504
[5]   Compliance with a statin treatment in a usual-care setting: Retrospective database analysis over 3 years after treatment initiation in health maintenance organization enrollees with dyslipidemia [J].
Caspard, H ;
Chan, AK ;
Walker, AM .
CLINICAL THERAPEUTICS, 2005, 27 (10) :1639-1646
[6]   Predictors of adherence with antihypertensive and lipid-lowering therapy [J].
Chapman, RH ;
Benner, JS ;
Petrilla, AA ;
Tierce, JC ;
Collins, SR ;
Battleman, DS ;
Schwartz, JS .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (10) :1147-1152
[7]   Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review [J].
De Vera, Mary A. ;
Bhole, Vidula ;
Burns, Lindsay C. ;
Lacaille, Diane .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (04) :684-698
[8]   Suboptimal statin adherence and discontinuation in primary and secondary prevention populations - Should we target patients with the most to gain? [J].
Ellis, JJ ;
Erickson, SR ;
Stevenson, JG ;
Bernstein, SJ ;
Stiles, RA ;
Fendrick, AM .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2004, 19 (06) :638-645
[9]   Estimates of Statin Discontinuation Rates Are Influenced by Exposure and Outcome Definitions [J].
Geers, Harm C. J. ;
Bouvy, Marcel L. ;
Heerdink, Eibert R. .
ANNALS OF PHARMACOTHERAPY, 2011, 45 (05) :576-581
[10]   Risks associated with statin therapy - A systematic overview of randomized clinical trials [J].
Kashani, Amir ;
Phillips, Christopher O. ;
Foody, JoAnne M. ;
Wang, Yongfei ;
Mangalmurti, Sandeep ;
Ko, Dennis T. ;
Krumholz, Harlan M. .
CIRCULATION, 2006, 114 (25) :2788-2797